BIOA -
BioAge Labs, Inc. Common Stock
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| 8.65 0.07 (0.81%) |
--- |
-0.06 (-0.68%) |
-0.16 (-1.8%) |
0.0 (0.0%) |
0.13 (1.51%) |
0.0 (0.0%) |
0.05 (0.58%) |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Earnings & Ratios
- Basic EPS:
- -0.6
- Diluted EPS:
- -0.6
- Basic P/E:
- -14.5333
- Diluted P/E:
- -14.5333
- RSI(14) 1m:
- 35.46
- VWAP:
- 8.73
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
Top 3 Biotech Stocks Capitalizing on the AI Revolution
Nov 18, 2025 18:02
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
Nov 07, 2025 14:00
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?
Oct 26, 2025 22:33
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
Aug 15, 2025 13:00
BioAge Labs (BIOA) Q2 Revenue Hits $2.4M
Aug 07, 2025 03:14
BIOA LEGAL NEWS: A Class Action was filed on behalf of BioAge Labs Investors - Contact BFA Law if You Suffered Losses
Mar 08, 2025 12:34
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Mar 05, 2025 17:00
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Mar 03, 2025 21:00
BIOA DEADLINE ALERT: BioAge Labs (BIOA) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 10th Deadline in Securities Class Action
Mar 02, 2025 18:14
BIOA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Mar 02, 2025 14:50